Erythropoietin receptor contributes to melanoma cell survival in vivoSuresh Kumar(University of Pennsylvania), Xiaowei Xu(Hospital of the University of Pennsylvania)OncogeneAugust 22, 201110.1038/onc.2011.366Cited by 55SaveCiteExport RISWatch citationsRelated PapersPatient-derived melanoma organoid models facilitate the assessment of immunotherapies|EBioMedicine|2023|81Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma|Oncotarget|2017|11Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti–PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free Survival|Clinical Cancer Research|2024|9